JNJ stock forecast 2026: what the data does and does not tell you

We publish no forecast for JNJ. Price targets are assumption-driven, and the ones that circulate publicly are revised after the price moves far more often than they anticipate it.

Our data shows a last traded price of $271.11 against a 52-week range of $173.33 – $274.90.

The price currently sits near the top of that range, which tells you about recent momentum, not about what comes next.

If you are researching JNJ because a fund you own holds it, the more useful question is how large that exposure already is, and whether you are comfortable with it in aggregate.

This is research, not advice, and we are not licensed to advise on individual securities.

Sector context worth holding in mind: JNJ is a Healthcare company, and sector-wide re-ratings move share prices independently of anything the company does.

If your interest in JNJ comes from a fund you already own, the more actionable step is checking the weight it carries there, rather than forming a view on the share price itself.

Research only — not advice, and not a recommendation to buy or sell.